Chlamydia infections are caused by the bacterium Chlamydia trachomatis and represent one of the most common sexually transmitted infections (STIs) globally. These infections can affect both men and women and often go unnoticed, as they may present with mild or no symptoms. Common symptoms include genital discharge, pain during urination, and pelvic pain in women. If left untreated, chlamydia infections can lead to serious complications, such as pelvic inflammatory disease (PID) in women, which may result in fertility issues. In men, untreated infections can cause epididymitis and, rarely, reactive arthritis. Diagnosis involves laboratory tests on samples from infected sites, and treatment typically consists of antibiotics, most commonly azithromycin or doxycycline. Regular screening and prompt treatment are essential to prevent complications and further transmission. Preventive measures include practicing safe sex, using condoms, and getting regular screenings, especially for individuals at higher risk. Given the often asymptomatic nature of chlamydia, raising awareness about STI testing and safe sexual practices is crucial for public health.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States